Evidence mapPaperPMID 36335116Full record

ArticleScientific reports2022

Association of apolipoprotein M and sphingosine-1-phosphate with brown adipose tissue after cold exposure in humans.

Anna Borup, Ida Donkin, Mariëtte R Boon, Martin Frydland, Borja Martinez-Tellez, Annika Loft, Sune H Keller, Andreas Kjaer, Jesper Kjaergaard, Christian Hassager and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Anna BorupDepartment of Clinical Biochemistry, Section 3-01-3, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Ida DonkinNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Mariëtte R BoonDepartment of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Martin FrydlandDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Borja Martinez-TellezDepartment of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Annika LoftDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
Sune H KellerDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
Andreas KjaerDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
Jesper KjaergaardDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Christian HassagerDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Romain BarrèsNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Patrick C N RensenDepartment of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Christina ChristoffersenDepartment of Clinical Biochemistry, Section 3-01-3, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. christina.christoffersen@regionh.dk.
Rigshospitalet · DKLeiden University Medical Center · NLUniversity of Copenhagen · DKBispebjerg Hospital · DKNovo Nordisk Foundation · DK

Funding

Dutch Diabetes Research Foundation 2015.81.1808Dutch Heart Foundation CVON2017-20 GENIUS-IINovo Nordisk Fonden NNF13OC0003898
6 · The paper itself

Abstract

The HDL-associated apolipoprotein M (apoM) and its ligand sphingosine-1-phosphate (S1P) may control energy metabolism. ApoM deficiency in mice is associated with increased vascular permeability, brown adipose tissue (BAT) mass and activity, and protection against obesity. In the current study, we explored the connection between plasma apoM/S1P levels and parameters of BAT as measured via

Indexed as

Adipose Tissue, BrownPositron Emission Tomography Computed TomographyAnimalsApolipoproteins MHumansLysophospholipidsSphingosineApolipoproteins MLysophospholipidsSphingosinesphingosine 1-phosphate

Identifiers

PMID36335116
PMCPMC9637161
OpenAlexW4308262120

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.